not
regulatory
2022-06-30 11:30
The National PKU Alliance (NPKUA) is the largest event for the PKU community in the world and brings together patients, relatives, industry, and research partners every two years. This year, Qlife…
regulatory
2022-06-28 15:36
The loans are granted by Modelio Equity AB and a large private shareholder in Qlife. The loan term runs over six months from June to December 2022. The loans are entered into on market terms of 1.5%…
not
regulatory
2022-06-27 15:44
In December 2021, Qlife signed an agreement with FIND for $ 3.45 million for a 12-month project with the goal of developing a new and cost-effective two-in-one test for influenza and SARS-CoV-2 virus…
not
regulatory
2022-06-20 09:02
By meeting regularly Qlife’s new Scientific Advisory Board will offer insights into the latest development within the specific fields of Molecular Diagnostics. The engagement of the members of the…
regulatory
2022-05-12 09:00
Qlife’s scientific team has completed the development of a blood-to-plasma filtration unit for blood-based biomarker testing. The Egoo capsule already integrates all reagents and with the new…
regulatory
2022-05-05 13:10
Resolution on adoption of accounts and distribution of the company’s result
The annual general meeting resolved to adopt the income statement and balance sheet as well as the consolidated income…
regulatory
2022-05-05 09:30
FINANCIAL SUMMARY – FIRST QUARTER 2022
Revenue in the period amounted to kSEK 10,905 (11,176). Revenue includes sales of Egoo.Health devices and capsules for the device. We saw strong sales…
regulatory
2022-04-06 13:00
Qlife Holding AB’s Annual report 2021 is from today available in swedish and english on the company’s website, www.qlifeholding.com.
https://qlifeholding.com/sv/investerare/finansiella-…
regulatory
2022-04-04 08:00
Right to participate and notification
Shareholders wishing to participate in the annual general meeting must:
partly be listed in the company’s share register kept by Euroclear Sweden AB as of…
not
regulatory
2022-03-28 10:42
The study set-up was using Hvidovre Hospital best practice for covid-19 testing (RT-qPCR) as the comparator method. Thus, the test execution deviates from the Egoo.Health Intended Use and Instruction…
not
regulatory
2022-02-17 10:12
"We are surprised that the results from the Danish clinical evaluation differ from previously scientific and published study on more than 1000 samples, which among others were conducted together…
regulatory
2022-02-17 09:30
FINANCIAL SUMMARY – FOURTH QUARTER 2021
Revenue in the period amounted to kSEK 12,084 (9,122). Revenue regards sales of Egoo.Health devices and COVID-19 test capsules.
EBITDA for the period…
regulatory
2021-12-20 16:00
Qlife has signed an agreement with FIND, the global alliance for diagnostics, for an funding of 3,45 MUSD for a 12-month project to develop a novel two-in-one assay for the detection of influenza and…
regulatory
2021-11-29 11:34
Kasper Rousøe has more than 20 years of experience from leading roles in the financial area, most recently from Phase One A/S. He has previously been CFO and Finance Director in Bauer Media Group,…
regulatory
2021-11-08 08:30
FINANCIAL SUMMARY – THIRD QUARTER 2021
Revenue in the period amounted to kSEK 5,871 (5,062). Sales regards COVID-19 tests from the test service center as well as Egoo.Health devices and capsules…
not
regulatory
2021-11-03 16:27
Today, most people get their diagnosis through so-called quantitative polymerase chain reaction (qRT-PCR) which is performed in specialized laboratories. This means that it often takes more than 24…
not
regulatory
2021-10-26 13:53
In accordance with the decision at Qlife Holding's Annual General Meeting 2021, the company's Chairman of the Board has convened a Nomination Committee to prepare proposals for the Company's Annual…
not
regulatory
2021-10-14 15:20
Wednesday, December 1 at Stora Aktiedagen in Stockholm
Time: 12.00-12.30
Thursday 2 December at Västra Hamnen in Malmö
Time: TBD
Investors, analysts and the media need to sign up for each event.…
regulatory
2021-09-21 16:30
“It has been a fantastic journey that I am proud to have been a part of. My expertise is primarily to assist companies in the start-up phase, and that is really not Qlife anymore, and therefore it is…
regulatory
2021-08-16 08:30
FINANCIAL SUMMARY – SECOND QUARTER 2021
Revenue in the period amounted to kSEK 10,482 (6,181). Sales regards COVID-19 tests from the test service center as well as Egoo.Health devices and capsules…
not
regulatory
2021-07-15 12:16
Today, most people get their diagnosis through so-called quantitative polymerase chain reaction (qRT-PCR) which is performed in specialized laboratories. This means that it often takes more than 24…
not
regulatory
2021-06-10 08:00
In connection with the European Football Championship in Copenhagen in the coming weeks, Qlife is expanding its testing capacity for Covid-19 to give more people access to RT-PCR tests with…
not
regulatory
2021-06-09 12:30
The division means that Thomas Warthoe’s, Peter Warthoe’s and Lars Bangsgaard's respective companies have acquired 1,201,200 shares each from PKV Consult IVS, and Ebbe Finding is now the sole owner…
regulatory
2021-06-02 08:00
The exercise period for the warrants of series TO 1 took place from May 3, 2021 up to and including May 31, 2021. The subscription price per share for the exercise of warrants of series TO 1 amounted…
regulatory
2021-05-20 08:00
At the Annual General Meeting on May 5, 2021, an incentive program aimed at three new board members of the company was resolved. The warrant terms are based on a market valuation according to…
not
regulatory
2021-05-18 08:00
The warrant holders have the right to subscribe for one (1) new share in Qlife for each two (2) owned warrants of series TO1 at a price of SEK 17.50 per share. The number of warrants of series TO1…
regulatory
2021-05-05 12:50
Resolution on adoption of accounts and allocation of the company’s result
The annual general meeting resolved to adopt the income statement and balance sheet as well as the consolidated income…
regulatory
2021-05-05 08:00
FINANCIAL SUMMARY - FIRST QUARTER 2021
Revenue in the period amounted to kSEK 11,176 (385). Revenue regards sales of COVID-19 tests from the test service center as well as Egoo.Health devices and…
not
regulatory
2021-05-03 08:00
The subscription period runs from 3 May 2021 until 31 May 2021. Two (2) warrants entitle to subscription of one (1) new share in the Company at a price of SEK 17.50 per share. If all warrants are…
regulatory
2021-04-29 19:02
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA (THE “UNITED STATES”), AUSTRALIA, CANADA, HONG KONG,…
not
regulatory
2021-04-23 11:30
Qlife invites investors, financial analysts and the media to a presentation where Thowas Warthoe will comment on the report. The report will be released at 08:…
regulatory
2021-04-22 14:25
Qlife has been part of a development programme at the oncology department at Herlev Hospital since 2018, intended to validate home monitoring of kidney cancer patients. The project has been delayed…
regulatory
2021-04-21 13:07
The agreement covers a range of European countries, including Sweden, Norway, Finland, Germany, Netherlands, Belgium, Luxembourg, Austria, Switzerland, Poland, Czech Republic, Hungary, Slovakia,…
regulatory
2021-04-12 08:00
The report can be downloaded from the website or ordered via the company; info@Egoo.health.This disclosure contains information that Qlife Holding AB is obliged to make public pursuant to the Swedish…
regulatory
2021-03-31 20:16
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.
The shareholders of Qlife Holding AB…
regulatory
2021-03-31 08:15
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.
In light of the ongoing Covid-19…
regulatory
2021-03-31 08:00
Qlife’s Nomination Committee proposes that the Annual General Meeting elects Mette-Marie Harild, Ulrik Harrysson and Mikael Persson as new Board members.
Mette-Marie Harild, born 1958, has a long…
regulatory
2021-02-18 10:00
FINANCIAL SUMMARY - FOURTH QUARTER 2020
Revenue in the period amounted to kSEK 9,122 (0). Sales regards COVID-19 test capacity to customers mainly within sports, through the partner KMD.
EBITDA…
not
regulatory
2021-01-29 08:00
“It is of great importance for Qlife to get a significant order from a highly professional customer directly after the CE-marking. It manifests the demand for tests of laboratory quality combined…
not
regulatory
2021-01-25 08:00
The Danish Patent Office has granted Qlife patent number DK180348 B1 for its biomarker detection unit. The biomarker detection unit consist of an integrated optical microelectromechanical system (…
not
regulatory
2021-01-07 08:00
The current CE-mark applies to the professional use of the test platform Egoo.Health for sale on the European market. The next step is to place the COVID-19 test in strategic locations, where it can…
regulatory
2020-12-22 10:59
Qlife expects to CE mark its COVID-19 test for professional use in the Egoo.Health system within short. With the CE mark, Qlife's cost-effective, fast, and mobile PCR tests can be marketed and sold…
not
regulatory
2020-11-30 08:00
Since May 2020, Qlife has been handling all testing for COVID-19 for professional football in Denmark. The test capacity includes weekly testing of all players and staff in league clubs in order to…
not
regulatory
2020-11-27 13:57
On November 13, Qlife was informed that the Danish Medicines Agency (Lægemiddelstyrelsen) had rejected the application for temporay approval in Denmark “in the interest of health protection” for the…
not
regulatory
2020-11-24 08:45
”We will do our utmost to protect the participating players against the coronavirus”, says Frank Smith, Covid-19 Officer, European Handball Federation Euro 2020 “It requires testing with high…
regulatory
2020-11-19 11:30
Resolution on (A) employee option program; and (B) directed issue of warrants and approval of transfer of warrants
The meeting resolved in accordance with the proposal from the board of directors to…
regulatory
2020-11-18 11:44
FINANCIAL SUMMARY - THIRD QUARTER 2020
Revenue in the period amounted to kSEK 5,062 (714). Sales regards COVID-19 test capacity to customers mainly within sports, through the partner KMD.
EBITDA…
regulatory
2020-11-13 17:55
In parallel to the ongoing process of preparing and putting together the dossier for the CE-mark, Qlife has submitted an application for placing the product on the market at this stage, as it offers…
not
regulatory
2020-11-03 09:03
The Nomination Committee consists of the following persons, who together represent approximately 39 percent of the company's shares and votes.
Sören Skjärbäk, appointed by PKV Consult IVS,
Sören…
regulatory
2020-11-02 08:30
Information regarding the coronavirus
As a precautionary measure to reduce the risk of spreading the coronavirus, the board of directors of Qlife Holding AB (”Qlife”) has decided to keep planned…
regulatory
2020-10-30 12:00
Qlife was originally expecting CE-mark for the product in October, but the company is now expecting approval within the coming two to three months. In the mean time, Qlife has submitted an…
not
regulatory
2020-08-21 13:55
Due to the increasing of infectious rates over the past few weeks, it has been agreed that Qlife will be handling all testing for COVID-19 for professional handball in Denmark. Testing will start…
regulatory
2020-08-18 09:45
FINANCIAL SUMMARY – SECOND QUARTER 2020
Revenue in the period amounted to kSEK 6,181 (0) and is mainly related to sales to KMD regarding the agreement with Danish Football League to test players…
not
regulatory
2020-07-30 15:14
In cooperation with KMD, Qlife has extended the contract with Divisionsforeningen. The extended contract is the continuation of COVID-19 testing of players and personnel in the two best football…
not
regulatory
2020-07-17 15:52
Qlife's focus on professional sports is centered around COVID-19 testing, which the company offers in collaboration with IT partner KMD. COVID-19 testing contracts have been closed with various…
regulatory
2020-07-08 08:30
Jakob has extensive experience from international sales and business development within MedTech and healthcare and brings an excellent record of results and achievements in complex and competitive…
not
regulatory
2020-07-06 14:55
In April we closed a contract with the professional Danish football league for regular testing of all players and staff for COVID-19 and delivery of test results were initiated already in week 22.…
regulatory
2020-06-22 15:58
"Henrik Ljung brings broad experience to Qlife from financial reporting, IR, business control, finance management and corporate governance, all with a focus on fast-growing companies in the early…
not
regulatory
2020-06-19 19:53
KMD and Qlife has entered an agreement with Badminton Denmark to COVID-19 test all players in the final game of the Danish badminton tournament for clubs, RSL Final 4.
"The fact that we COVID-19…
not
regulatory
2020-06-04 11:25
Geelmuyden Kiese and KMD announced earlier today that they have entered a partnership to provide smart and efficient Covid-19 test solutions for the professional sports, culture, and entertainment…
not
regulatory
2020-06-02 10:27
The first phase of developing the antibody test will be outsourced to an existing partner and is expected to take approximately three months. Thereafter, the project will be transferred to in-house…
regulatory
2020-05-20 14:00
Resolution on adoption of accounts and allocation of the company’s result
The annual general meeting resolved to adopt the income statement and balance sheet as well as the consolidated income…
regulatory
2020-05-20 08:15
FINANCIAL SUMMARY FIRST QUARTER 2020
Revenue for the period amounted to kSEK 385 (0) and regards a collaboration project with a Danish hospital.
EBITDA for the period amounted to kSEK -5,732 (-1,…
regulatory
2020-05-12 16:35
The parties have agreed a testing plan for all players, judges and club staff for Covid-19 in the professional leagues (3F SuperLiga and NordicBet Liga). The parties have developed a test protocol…
not
regulatory
2020-04-22 10:55
Qlife announces that it has entered into a research agreement with Nordsjællands Hospital (NOH), to continue the validation of the Egoo Sars-CoV-2 virus test. The focus of the collaboration is to…
regulatory
2020-04-16 10:00
Information regarding the coronavirus
As a precautionary measure to reduce the risk of spreading the coronavirus, the board of directors of Qlife Holding AB (”Qlife”) has decided to keep planned…
not
regulatory
2020-04-03 15:50
Due to increased requests for information on route to market for Qlife’s COVID-19 test the company is updating the following:
After having finalized the licensing agreement to COVID-19…
regulatory
2020-03-31 16:55
Qlife announces that it has closed a license and supply agreement with Aidian Oy to access and incorporate their patented SIBA® Technology into the Egoo.Health platform. The companies have…
not
regulatory
2020-03-13 16:30
Qlife went public on March 2 with a clear strategy for the next year, that strategy is still being followed and we do not see any large obstacles to it due to the Corona virus outbreak. The interest…
not
regulatory
2020-03-02 08:45
Qlife Holding AB announces that the trading in the company’s shares (short name: QLIFE) will commence today on the Nasdaq First North Growth Market in Stockholm. Qlife Holding AB (“Qlife”) belongs to…
not
regulatory
2020-02-28 12:16
The short name for the Company’s shares on Nasdaq First North is QLIFE. The short name for the TO1 series warrants is QLIFE TO1.
Qlife has appointed G&W Fondkommission as certified advisor (…
not
regulatory
2020-01-29 12:30
The Egoo Home System is an integrated platform consisting of a small device, disposable capsules, each a test for a specific biomarker, and a digital infrastructure that can share data with patient…
not
regulatory
2019-11-28 10:37
CEO Thomas Warthoe will present Qlife at Stora Aktiedagen (Shareholder’s Day) in Stockholm on 25 November. Would you like to read more about the programme and how to sign up, see attached…
not
regulatory
2019-11-06 10:20
CEO Thomas Warthoe will present Qlife at Stora Aktiedagen (Shareholder’s Day) in Gothenburg on 4 November and in Stockholm on 25 November. Would you like to read more about the programme and how to…
not
regulatory
2019-11-06 09:11
The home diagnostic device from Danish start-up Qlife can make the lives of patients with chronic diseases easier. This is the way forward towards a more human centered public health sector, says one…
not
regulatory
2019-10-31 14:18
Qlife is showcased by the Danish Minister of Health and the Minister for Industry, Business and Financial Affairs for the launch of new public program for innovative purchasing of medical equipment…
not
regulatory
2019-10-16 16:20
In the enclosed Newsletter you will find updated information about our operations and preparations for next steps.
not
regulatory
2019-10-14 10:58
Biomarkers in our blood can show us a lot about our health, the development of a disease or how tough we have been to our body during a workout. Up until now, these bio markers could only be measured…
not
regulatory
2019-10-14 10:53
Every day, the Danish healthcare system produces a large amount of data. In the future, new data sources, such as data from patients, personal health tools and apps, will substantially…
not
regulatory
2019-10-14 10:51
Six interesting companies in total will present their businesses.
Watch the video of the presentation